Evaxion Biotech A/S ADR [NASDAQ: EVAX] price surged by 36.25 percent to reach at $0.87.
The one-year EVAX stock forecast points to a potential upside of 89.76. The average equity rating for EVAX stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Evaxion Biotech A/S ADR [EVAX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EVAX shares is $31.92 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EVAX stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Evaxion Biotech A/S ADR shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 02, 2024. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on February 12, 2024, representing the official price target for Evaxion Biotech A/S ADR stock.
The Average True Range (ATR) for Evaxion Biotech A/S ADR is set at 1.16, with the Price to Sales ratio for EVAX stock in the period of the last 12 months amounting to 1.16. The Price to Book ratio for the last quarter was 2.82, with the Price to Cash per share for the same quarter was set at 3.91.
EVAX Stock Performance Analysis:
Evaxion Biotech A/S ADR [EVAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -25.17. With this latest performance, EVAX shares dropped by -29.24% in over the last four-week period, additionally sinking by -75.32% over the last 6 months – not to mention a drop of -85.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EVAX stock in for the last two-week period is set at 44.10, with the RSI for the last a single of trading hit 46.12, and the three-weeks RSI is set at 42.17 for Evaxion Biotech A/S ADR [EVAX]. The present Moving Average for the last 50 days of trading for this stock 5.11, while it was recorded at 2.80 for the last single week of trading, and 12.89 for the last 200 days.
Insight into Evaxion Biotech A/S ADR Fundamentals:
Evaxion Biotech A/S ADR’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.80 and a Current Ratio set at 2.80.
